MYCN and neuroblastoma: Besides age of onset, primary location, and metastasis, MYCN amplification is widely considered to correlate with risk stratification, relapse, progressive disease, and unfavorable survival rate in NB patients [5, 10, 11, 12, 13, 14, 15, 16, 17].